(Q41944990)

English

Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

hydroxychloroquine

1 reference

based on heuristic

inferred from title

Michelle A. Petri

5

object named as

M Petri

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

N Kasitanon

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

D M Fine

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

M Haas

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

L S Magder

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

366-370

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

The classification of glomerulonephritis in systemic lupus erythematosus revisited

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2313OA

21 January 2018

Identifiers

10.1191/0961203306LU2313OA

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41944990&oldid=1930121509"